Expression and modulation of CD44 variant isoforms in humans - PubMed (original) (raw)

Expression and modulation of CD44 variant isoforms in humans

C R Mackay et al. J Cell Biol. 1994 Jan.

Abstract

CD44 is a ubiquitous surface molecule that exists as a number of isoforms, generated by alternative splicing of 10 "variant" exons. Little is known about the expression and function of the variant isoforms, except that certain isoforms may play a role in cancer metastasis. We produced mAbs against CD44 variant regions encoded by exons 4v, 6v, and 9v, by immunizing mice with a fusion protein spanning variant exons 3v to 10v. A comprehensive analysis of human tissues revealed that CD44 variant isoforms were expressed widely throughout the body, principally by epithelial cells. However there was differential expression of CD44 variant exons by different epithelia. Most epithelia expressed exon 9v, but much fewer expressed 6v or 4v. The regions of epithelia that expressed the highest levels of the variant isoforms were the generative cells, particularly the basal cells of stratified squamous epithelium, and of glandular epithelium. CD44 variant isoforms were also expressed differentially by leukocytes, with CD44-9v expressed at very low levels and CD44-6v and 4v virtually absent. However, CD44-9v and CD44-6v were the main variants that were transiently upregulated on T cells after mitogenic stimulation and on myelomonocytic cell lines by TNF alpha and IFN gamma treatment. Some epithelial cell lines could preferentially upregulate CD44-6v upon IFN gamma incubation. These results show that CD44 variant isoforms are expressed much more widely than first appreciated, and that expression of the variant isoforms on some cell types can be modulated by particular cytokines.

PubMed Disclaimer

Similar articles

• CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
  Stauder R, Eisterer W, Thaler J, Günthert U. Stauder R, et al. Blood. 1995 May 15;85(10):2885-99. Blood. 1995. PMID: 7537983
• CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
  Terpe HJ, Stark H, Prehm P, Günthert U. Terpe HJ, et al. Histochemistry. 1994 Feb;101(2):79-89. doi: 10.1007/BF00269353. Histochemistry. 1994. PMID: 7520892
• [Occurrence of CD44 and its isoforms under orthological and pathological conditions].
  Terpe A, Franke F, Stark H, Gustmann C, Mackay C, Marston W, Günthert U. Terpe A, et al. Verh Dtsch Ges Pathol. 1993;77:276-81. Verh Dtsch Ges Pathol. 1993. PMID: 7511297 German.
• The CD44 adhesion molecule and metastasis.
  Tanabe KK, Saya H. Tanabe KK, et al. Crit Rev Oncog. 1994;5(2-3):201-12. doi: 10.1615/critrevoncog.v5.i2-3.50. Crit Rev Oncog. 1994. PMID: 7531501 Review.
• CD44: a multitude of isoforms with diverse functions.
  Günthert U. Günthert U. Curr Top Microbiol Immunol. 1993;184:47-63. doi: 10.1007/978-3-642-78253-4_4. Curr Top Microbiol Immunol. 1993. PMID: 7508842 Review. No abstract available.

Cited by

• The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4.
  Stickeler E, Fraser SD, Honig A, Chen AL, Berget SM, Cooper TA. Stickeler E, et al. EMBO J. 2001 Jul 16;20(14):3821-30. doi: 10.1093/emboj/20.14.3821. EMBO J. 2001. PMID: 11447123 Free PMC article.
• Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.
  Silva VR, Santos LS, Dias RB, Quadros CA, Bezerra DP. Silva VR, et al. Cancer Commun (Lond). 2021 Dec;41(12):1275-1313. doi: 10.1002/cac2.12235. Epub 2021 Nov 17. Cancer Commun (Lond). 2021. PMID: 34791817 Free PMC article. Review.
• Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44.
  Kawasaki N, Matsuo Y, Yoshino T, Yanai H, Oka T, Teramoto N, Liu C, Kondo E, Minowada J, Akagi T. Kawasaki N, et al. Jpn J Cancer Res. 1996 Oct;87(10):1070-7. doi: 10.1111/j.1349-7006.1996.tb03112.x. Jpn J Cancer Res. 1996. PMID: 8957066 Free PMC article.
• Expression of CD44 variants and its association with survival in pancreatic cancer.
  Gotoda T, Matsumura Y, Kondo H, Saitoh D, Shimada Y, Kosuge T, Kanai Y, Kakizoe T. Gotoda T, et al. Jpn J Cancer Res. 1998 Oct;89(10):1033-40. doi: 10.1111/j.1349-7006.1998.tb00493.x. Jpn J Cancer Res. 1998. PMID: 9849582 Free PMC article.
• Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
  Reinisch W, Heider KH, Oberhuber G, Dejaco C, Müllner M, Adolf GR, Gasché C. Reinisch W, et al. Gut. 1998 Sep;43(3):375-82. doi: 10.1136/gut.43.3.375. Gut. 1998. PMID: 9863483 Free PMC article.

References

1. 1. Gene. 1988 Jul 15;67(1):31-40 - PubMed
2. 1. J Exp Med. 1993 Feb 1;177(2):443-55 - PubMed
3. 1. Science. 1992 Jul 31;257(5070):682-5 - PubMed
4. 1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
5. 1. Am J Anat. 1974 Dec;141(4):461-79 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • Cellosaurus - a cell line knowledge resource

• Miscellaneous

  • NCI CPTAC Assay Portal